Study design of the first phase I/II clinical trial of lentivirus-mediated gene therapy of the β-hemoglobinopathies and future strategies for selection of transduced cells
Philippe LeboulchVolume:
38
Year:
2007
Language:
english
Pages:
153
DOI:
10.1016/j.bcmd.2006.10.077
File:
PDF, 67 KB
english, 2007